Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
787.02 | -49,84% | -29,25% | 708.637,05 | 0,68% | 2,63% |
|
NYSE:JNJ
Johnson & Johnson
|
152.67 | 0% | 0% | 367.427,71 | 3,28% | 2,71% |
|
NYSE:MRK
Merck
|
131.73 | -10,39% | 2,75% | 333.646,57 | 2,39% | -19,03% |
|
LSE:AZN
AstraZeneca PLC
|
121.72 | 18,28% | 40,89% | 188.694,61 | 2,01% | 15,98% |
|
SWX:NOVN
Novartis
|
93.30 | 8,23% | 21,62% | 190.369,92 | 3,53% | 4,67% |
|
SWX:ROG
Roche Holding
|
227.50 | 30,63% | 46,57% | 183.645,06 | 4,27% | 0,43% |
|
NasdaqGS:AMGN
Amgen
|
319.04 | -14,06% | -5,45% | 171.144,12 | 2,89% | 5,31% |
|
NYSE:PFE
Pfizer
|
28.82 | 7,74% | 37,79% | 163.311,21 | 5,92% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
90.56 | 17,5% | 36,18% | 113.210,59 | 4,1% | 8,19% |
|
LSE:GSK
GSK
|
18.13 | 5,18% | 20,68% | 73.914,43 | 3,2% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.55 | 59,85% | 70,07% | 90.307,31 | 5,37% | 13,54% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.01 | 22,18% | 31,53% | 83.479,36 | 4,55% | 0,15% |
|
XTRA:MRK
Merck KGaA
|
165.85 | 3,79% | 18,65% | 72.107,91 | 1,39% | 10,73% |
|
TSE:4568
Daiichi Sankyo Company
|
5486.00 | 0% | 0% | 10.516.360,76 | 1,11% | 0% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4159.00 | 0% | 0% | 6.525.195,89 | 4,66% | 0% |
|
NasdaqGS:BIIB
Biogen
|
235.32 | -16,94% | -2,2% | 34.261,86 | 0% | -10,89% |
|
XTRA:BAYN
Bayer
|
29.33 | 63,25% | 79,18% | 28.809,59 | 0,38% | 1,47% |
|
NasdaqGS:BNTX
BioNTech
|
92.20 | 0% | 0% | 22.219,32 | 0% | 299,65% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
147.40 | 0% | 0% | 18.644,89 | 0% | 0% |
|
TSE:4503
Astellas Pharma
|
1525.00 | 0% | 0% | 2.734.304,3 | 4,87% | 0% |
